No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr6:167043400-167058200 |
Weak transcription |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
2 |
chr6:167045000-167061200 |
Weak transcription |
H9 Cell Line |
embryonic stem cell
|
3 |
chr6:167046600-167054600 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
4 |
chr6:167047600-167061200 |
Weak transcription |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
5 |
chr6:167048800-167054000 |
Weak transcription |
H1 Cell Line |
embryonic stem cell
|
6 |
chr6:167050600-167053600 |
Weak transcription |
Duodenum Smooth Muscle |
Duodenum
|
7 |
chr6:167050800-167053800 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
8 |
chr6:167050800-167054200 |
Weak transcription |
Gastric |
stomach
|
9 |
chr6:167051000-167053800 |
Weak transcription |
Stomach Smooth Muscle |
stomach
|
10 |
chr6:167051000-167054000 |
Weak transcription |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
11 |
chr6:167051000-167054200 |
Weak transcription |
Esophagus |
oesophagus
|
12 |
chr6:167051200-167054000 |
Weak transcription |
ES-UCSF4 Cell Line |
embryonic stem cell
|
13 |
chr6:167051200-167054000 |
Weak transcription |
Skeletal Muscle Male |
skeletal muscle
|
14 |
chr6:167051400-167053800 |
Weak transcription |
Right Atrium |
heart
|
15 |
chr6:167051400-167054000 |
Weak transcription |
Brain Inferior Temporal Lobe |
brain
|
16 |
chr6:167051400-167054200 |
Weak transcription |
Lung |
lung
|
17 |
chr6:167051600-167053800 |
Weak transcription |
Right Ventricle |
heart
|
18 |
chr6:167052800-167054000 |
Enhancers |
Left Ventricle |
heart
|
19 |
chr6:167052800-167054600 |
Enhancers |
Fetal Heart |
heart
|
20 |
chr6:167053000-167053800 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
21 |
chr6:167053000-167054400 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
22 |
chr6:167053000-167054600 |
Enhancers |
Fetal Muscle Leg |
muscle
|
23 |
chr6:167053200-167053600 |
Bivalent Enhancer |
Primary T cells from cord blood |
blood
|
24 |
chr6:167053200-167053800 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
25 |
chr6:167053200-167053800 |
Enhancers |
NHEK |
skin
|
26 |
chr6:167053200-167054000 |
Bivalent Enhancer |
Adipose Nuclei |
Adipose
|
27 |
chr6:167053200-167054400 |
Flanking Active TSS |
HUVEC |
blood vessel
|
28 |
chr6:167053400-167053600 |
Flanking Active TSS |
Primary hematopoietic stem cells |
blood
|
29 |
chr6:167053400-167054000 |
Enhancers |
iPS-18 Cell Line |
embryonic stem cell
|
30 |
chr6:167053400-167054200 |
Bivalent Enhancer |
Primary B cells from peripheral blood |
blood
|
31 |
chr6:167053400-167054200 |
Enhancers |
Primary T helper memory cells from peripheral blood 2 |
blood
|
32 |
chr6:167053400-167054200 |
Enhancers |
Primary T killer naive cells fromperipheralblood |
blood
|
33 |
chr6:167053400-167054400 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
34 |
chr6:167053400-167054400 |
Bivalent Enhancer |
Primary B cells from cord blood |
blood
|
35 |
chr6:167053400-167054400 |
Bivalent Enhancer |
Primary T helper cells fromperipheralblood |
blood
|
36 |
chr6:167053400-167054400 |
Weak transcription |
Spleen |
Spleen
|
37 |
chr6:167053400-167054600 |
Enhancers |
Primary T helper 17 cells PMA-I stimulated |
--
|